$APM - Aptorum Shares Rise After FDA Orphan Drug Tag For Repurposed Compound For Pediatric Cancer (1/20/2022): https://finance.yahoo.com/news/aptorum-shares-rise-fda-orphan-134714476.html
$SRRA - Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis: https://finance.yahoo.com/news/sierra-oncology-announces-momelotinib-achieved-120000858.html